Form D · Other Technology
BioViva USA Inc
Bianbridge Island, WA · CIK 0001643307
Offering snapshot reported Apr 25, 2022 · SEC filing
- Reported sold
- $200K Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Dec 7, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 25, 2022 | Initial | $200,000 | No comparison | 1 | SEC filing |
| May 27, 2015 | Initial | $0 | No comparison | 0 | SEC filing |
| May 27, 2015 | Amendment | $250,000 | $250,000vs May 27, 2015 | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-443272
Source: Form D, filed Apr 25, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Elizabeth Parrish | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
6580 Ne Honeysuckle Lane
Bianbridge Island, WA, 98110
Bianbridge Island, WA, 98110